Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
On Oct. 16, 2026, GRDN is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
Guardian Pharmacy Services, Inc. is a mid-cap company with a market capitalization of $2.50B. It ranks number 2 by market capitalization among the 5 Retail-Drug Stores and Proprietary Stores issuers in our coverage with a current forecast.
For GRDN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 50.0%, measured on 237 forecast dates between 2024-11-15 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 25.0%, measured on 280 forecast dates between 2024-11-15 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, GRDN included.
Follow GRDN free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Retail-Drug Stores and Proprietary Stores peers listed below that report each metric.
| Metric | GRDN | Rank |
|---|---|---|
| Market Cap | $2.50B | 2/5 |
| P/E Ratio | 37.93x | – |
| P/B Ratio | 10.18x | – |
| Book Value/Share | $3.88 | – |
| Revenue/Share | $23.10 | – |
| Metric | GRDN | Rank |
|---|---|---|
| ROE | 26.8% | – |
| ROA | 14.9% | – |
| ROIC | 29.5% | – |
| Gross Margin | 21.6% | – |
| Operating Margin | 5.8% | – |
| Net Margin | 4.5% | – |
| EBT Margin | 6.5% | – |
| Tax Rate | 30.6% | – |
| Metric | GRDN | Rank |
|---|---|---|
| Current Ratio | 1.65x | – |
| Quick Ratio | 1.33x | – |
| D/E Ratio | 0.76x | – |
| Financial Leverage | 1.81x | – |
| Interest Coverage | 33.9x | – |
| Working Capital | $101M | – |
| Metric | GRDN | Rank |
|---|---|---|
| Operating Cash Flow | $99M | – |
| Metric | GRDN | Rank |
|---|---|---|
| Asset Turnover | 3.30x | – |
| Receivables Turnover | 14.1x | – |
| Inventory Turnover | 22.7x | – |
| Fixed Assets Turnover | 25.9x | – |
| Days Sales Outstanding | 26 days | – |
| Days Inventory | 16 days | – |
| Payables Period | 34 days | – |
| Cash Conversion Cycle | 8 days | – |
| Metric | GRDN | Rank |
|---|---|---|
| Total Revenue | $1.46B | – |
| Operating Income | $85M | – |
| Net Income | $66M | – |
| SG&A Expense | $231M | – |
| Cost of Goods Sold | $1.15B | – |
| Metric | GRDN | Rank |
|---|---|---|
| Shares Outstanding | 63M | – |
| Total Current Assets | $255M | 57.4% of assets |
| Cash & Short-term Investments | $90M | 20.2% of assets |
| Accounts Receivable | $104M | 23.4% of assets |
| Inventory | $50M | 11.4% of assets |
| Total Liabilities | $186M | 41.9% of assets |
| Short-term Debt | $46M | 10.3% of assets |
Companies classified under the same SEC industry code as Guardian Pharmacy Services, Inc. (Retail-Drug Stores and Proprietary Stores): 5 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeThe above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Good afternoon, and we're here for our last presentation of the day, but saving the best for last, right? So we have a Guardian Pharmacy Services as our next presenter. I've got Fred Burke, the ...
On Oct. 16, 2026, GRDN is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
For GRDN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 50.0%, measured on 237 forecast dates between 2024-11-15 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 25.0%, measured on 280 forecast dates between 2024-11-15 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Guardian Pharmacy Services, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
5 issuers in our coverage, GRDN included, share the SEC industry code Retail-Drug Stores and Proprietary Stores. The largest are: Cvs Health Corp (CVS), Trees Corp (Colorado) (CANN), Petmed Express Inc (PETS), Ridgetech Inc. (RDGT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.